查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555648

迷走神經刺激市場：2024-2031年全球產業分析、規模、佔有率、成長、趨勢、預測

Vagus Nerve Stimulation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 181 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份有關全球迷走神經刺激（VNS）市場的詳細報告。本報告對市場驅動因素、趨勢、機會和挑戰等關鍵市場動態進行了全面分析，提供了對市場結構的深入見解。

主要見解

  • 迷走神經刺激療法市場規模（2024年）：5.659億美元
  • 預測市場規模（2031年）：7.831億美元
  • 全球市場成長率（2024-2031年年複合成長率）：8.5%

迷走神經刺激市場 - 報告範圍：

迷走神經刺激市場涵蓋用於非侵入性和植入性刺激迷走神經的裝置。這些設備已廣泛用於治療傳統療法無效的神經系統疾病，例如癲癇和憂鬱症。該市場服務於各種醫療保健環境，包括醫院、診所和家庭醫療保健。神經系統疾病盛行率不斷上升以及 VNS 設備技術進步改善了治療效果，推動了市場成長。擴展到新興市場、擴大其他治療領域的應用以及對非侵入性醫療保健解決方案不斷成長的需求促進市場的強勁成長。

推動市場成長的因素：

迷走神經刺激的全球市場主要是由癲癇、憂鬱症和偏頭痛等神經系統疾病發病率的增加所推動的。 VNS療法在傳統治療失敗時顯示出療效，並已成為醫療保健領域的重要選擇。技術進步，尤其是 VNS 設備中人工智慧（AI）和機器學習的整合，實現個人化治療計劃，進一步推動市場發展。此外，VNS 療法在慢性心臟衰竭和肥胖等疾病中的廣泛應用開闢新的成長途徑。

市場限制因素：

儘管 VNS 市場潛力巨大，但仍面臨一些挑戰。醫療保健專業人員和患者對迷走神經刺激療法的益處認識有限可能會阻礙市場成長。此外，與植入式設備相關的高成本和手術問題也減少了患者的採用。醫療器材審批的監管障礙和嚴格要求進一步減緩了市場進入，特別是在新興市場。 VNS 在不同疾病狀態下使用的標準化方案的缺乏也限制了 VNS 的廣泛接受。

市場機會：

VNS 市場提供了巨大的機會，特別是在對先進神經治療方案的需求不斷增加的新興國家。非侵入性 VNS 設備的開發以及神經系統疾病以外的應用擴展是主要的成長領域。醫療保健提供者和 VNS 設備製造商之間的合作可以進一步加速市場滲透。家庭醫療保健趨勢和電子商務平台上設備可用性的增加也推動了 VNS 治療的更廣泛普及，並支持未來的市場擴張。

本報告涵蓋的主要問題

  • 推動迷走神經刺激市場全球成長的關鍵因素是什麼？
  • 哪些類型的VNS 設備在各種環境中的採用率領先？
  • 技術進步如何影響 VNS 市場的競爭格局？
  • 誰是 VNS 市場的主要參與者？ 他們採取什麼策略來保持競爭力？
  • 全球迷走神經刺激市場有哪些新趨勢與未來前景？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 世界產業展望
    • 世界 GDP 成長前景
    • 全球醫療保健支出前景
  • 新冠肺炎（COVID-19）影響分析
  • 預測因子 - 相關性和影響

第3章 增值見解

  • 產品採用率分析
  • 技術評估
  • 監理狀況
  • 價值鏈分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 2019-2031年價格趨勢分析

  • 主要亮點
  • 影響產品價格的主要因素
  • 以產品進行價格分析
  • 區域價格與產品偏好

第5章 全球迷走神經刺激市場展望：過去（2019-2023年）與預測（2024-2031年）

  • 主要亮點
    • 市場規模（數量）預測
    • 市場規模（金額）及年比成長率
    • 絕對的機會
  • 市場規模（金額）分析與預測
    • 過去的市場規模（金額）分析，2019-2023年
    • 2023-2031年目前市場規模（金額）分析與預測
  • 全球迷走神經刺激市場展望：產品
    • 簡介/主要調查結果
    • 過去的市場規模（金額和數量）分析，2019-2023年
    • 2024-2031年當前市場規模（金額和數量）分析與預測
      • 嵌入式 VNS 設備
      • 外部 VNS 設備
  • 市場吸引力分析：產品
  • 全球迷走神經刺激市場展望：生物材料
    • 簡介/主要調查結果
    • 過去的市場規模（金額）分析，2019-2023年
    • 2024-2031年目前市場規模（金額）分析與預測
      • 金屬
      • 陶瓷
      • 聚合物
  • 市場吸引力分析：生物材料
  • 全球迷走神經刺激市場展望：應用
    • 簡介/主要調查結果
    • 過去的市場規模（金額）分析，2019-2023年
    • 2024-2031年目前市場規模（金額）分析與預測
      • 癲癇
      • 憂鬱症
      • 偏頭痛
  • 市場吸引力分析：應用

第6章 全球迷走神經刺激市場展望：地區

  • 主要亮點
  • 過去的市場規模（金額和數量）分析，2019-2023年
  • 2024-2031年當前市場規模（金額和數量）分析與預測
    • 北美
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第7章 北美迷走神經刺激市場展望：過去（2019-2023）與預測（2024-2031）

第8章 歐洲迷走神經刺激市場展望：過去（2019-2023年）與預測（2024-2031年）

第9章 東亞迷走神經刺激市場展望：過去（2019-2023年）與預測（2024-2031年）

第10章 南亞與大洋洲迷走神經刺激市場展望：過去（2019-2023）與預測（2024-2031）

第11章 拉丁美洲迷走神經刺激市場展望：過去（2019-2023年）與預測（2024-2031年）

第12章 中東與非洲迷走神經刺激市場展望：過去（2019-2023）與預測（2024-2031）

第13章 競爭態勢

  • 2023年市佔率分析
  • 市場結構
    • 依市場劃分的競爭強度圖
    • 競爭儀表板
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Soterix Medical Inc.
    • MicroTransponder Inc
    • Beijing PINS Medical Co., Ltd
    • LivaNova PLC
    • Neuropix Company Ltd.
    • Parasym Ltd
    • electroCore, Inc.
    • tVNS Health GmbH
    • SetPoint Medical Corporation

第14章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34750

Persistence Market Research has recently published an extensive report on the global Vagus Nerve Stimulation (VNS) Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Vagus Nerve Stimulation Market Size (2024E): USD 565.9 Mn
  • Projected Market Value (2031F): USD 783.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.5%

Vagus Nerve Stimulation Market - Report Scope:

The Vagus Nerve Stimulation Market covers devices used for non-invasive and implantable stimulation of the vagus nerve. These devices have been widely employed in treating neurological disorders such as epilepsy and depression, where conventional treatments have not been effective. The market caters to different healthcare settings, including hospitals, clinics, and home care. Market growth is driven by the rising prevalence of neurological conditions and technological advancements in VNS devices that offer improved treatment outcomes. Expansion into emerging markets, growing applications in other therapeutic areas, and increasing demand for non-invasive healthcare solutions contribute to the market's robust growth.

Market Growth Drivers:

The global Vagus Nerve Stimulation Market is primarily driven by the increasing incidence of neurological disorders such as epilepsy, depression, and migraines. VNS therapy has shown effectiveness in cases where traditional treatments have failed, making it a crucial option in the healthcare sector. Technological advancements, particularly the integration of artificial intelligence (AI) and machine learning in VNS devices, allow personalized treatment plans, further propelling the market. Additionally, expanding applications of VNS therapy to conditions such as chronic heart failure and obesity are opening new growth avenues.

Market Restraints:

Despite its potential, the VNS market faces several challenges. Limited awareness among healthcare professionals and patients regarding the benefits of VNS therapy can hinder market growth. Additionally, high costs associated with implantable devices and concerns about surgical procedures reduce patient adoption. Regulatory barriers and stringent requirements for medical device approvals further delay market entry, particularly in emerging markets. A lack of standardized protocols for the use of VNS across different conditions also restricts its broader acceptance.

Market Opportunities:

The VNS market presents significant opportunities, especially in emerging economies where the demand for advanced neurological treatment options is rising. The development of non-invasive VNS devices and expanding applications beyond neurological disorders represent key growth areas. Collaborations between healthcare providers and VNS device manufacturers can further accelerate market penetration. The growing trend of home healthcare and the increasing availability of devices through e-commerce platforms are also facilitating wider access to VNS therapy, driving future market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Vagus Nerve Stimulation Market globally?
  • Which types of VNS devices are leading the adoption in various settings?
  • How are technological advancements influencing the competitive landscape of the VNS market?
  • Who are the key players in the VNS market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Vagus Nerve Stimulation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Vagus Nerve Stimulation Market are focusing on product innovation, technological advancements, and strategic partnerships. Companies are investing in research and development to enhance the efficacy and accessibility of VNS devices. Collaborations with healthcare institutions and partnerships with governments to introduce devices in emerging economies help expand market reach. As healthcare providers recommend VNS therapy for a broader range of conditions, product differentiation and quality assurance will be crucial for maintaining a competitive edge in the market.

Key Market Players

  • Soterix Medical Inc.
  • MicroTransponder Inc
  • Beijing PINS Medical Co., Ltd
  • LivaNova PLC
  • Neuropix Company Ltd.
  • Parasym Ltd
  • electroCore, Inc.
  • tVNS Health GmbH
  • SetPoint Medical Corporation

Vagus Nerve Stimulation Industry Segmentation

By Product

  • Implantable VNS Device
  • External VNS Device

By Biomaterial

  • Metallic
  • Ceramics
  • Polymeric

By Application

  • Epilepsy
  • Depression
  • Migraine

By Region

  • North America
  • Latin America
  • Europe
  • South Asia & Oceania
  • East Asia
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Vagus Nerve Stimulation Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2031

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
  • 5.3. Global Vagus Nerve Stimulation Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
      • 5.3.3.1. Implantable VNS Device
      • 5.3.3.2. External VNS Device
  • 5.4. Market Attractiveness Analysis: Product
  • 5.5. Global Vagus Nerve Stimulation Market Outlook: Biomaterial
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Biomaterial, 2019-2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
      • 5.5.3.1. Metallic
      • 5.5.3.2. Ceramics
      • 5.5.3.3. Polymeric
  • 5.6. Market Attractiveness Analysis: Biomaterial
  • 5.7. Global Vagus Nerve Stimulation Market Outlook: Application
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
      • 5.7.3.1. Epilepsy
      • 5.7.3.2. Depression
      • 5.7.3.3. Migraine
  • 5.8. Market Attractiveness Analysis: Application

6. Global Vagus Nerve Stimulation Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Biomaterial
    • 7.3.4. By Application
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.4.1. U.S.
    • 7.4.2. Canada
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 7.5.1. Implantable VNS Device
    • 7.5.2. External VNS Device
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 7.6.1. Metallic
    • 7.6.2. Ceramics
    • 7.6.3. Polymeric
  • 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 7.7.1. Epilepsy
    • 7.7.2. Depression
    • 7.7.3. Migraine
  • 7.8. Market Attractiveness Analysis

8. Europe Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Biomaterial
    • 8.3.4. By Application
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. U.K.
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Turkey
    • 8.4.8. Rest of Europe
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 8.5.1. Implantable VNS Device
    • 8.5.2. External VNS Device
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 8.6.1. Metallic
    • 8.6.2. Ceramics
    • 8.6.3. Polymeric
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 8.7.1. Epilepsy
    • 8.7.2. Depression
    • 8.7.3. Migraine
  • 8.8. Market Attractiveness Analysis

9. East Asia Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Biomaterial
    • 9.3.4. By Application
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 9.5.1. Implantable VNS Device
    • 9.5.2. External VNS Device
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 9.6.1. Metallic
    • 9.6.2. Ceramics
    • 9.6.3. Polymeric
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 9.7.1. Epilepsy
    • 9.7.2. Depression
    • 9.7.3. Migraine
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Biomaterial
    • 10.3.4. By Application
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.4.1. India
    • 10.4.2. Southeast Asia
    • 10.4.3. ANZ
    • 10.4.4. Rest of South Asia & Oceania
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 10.5.1. Implantable VNS Device
    • 10.5.2. External VNS Device
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 10.6.1. Metallic
    • 10.6.2. Ceramics
    • 10.6.3. Polymeric
  • 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 10.7.1. Epilepsy
    • 10.7.2. Depression
    • 10.7.3. Migraine
  • 10.8. Market Attractiveness Analysis

11. Latin America Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Biomaterial
    • 11.3.4. By Application
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 11.5.1. Implantable VNS Device
    • 11.5.2. External VNS Device
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 11.6.1. Metallic
    • 11.6.2. Ceramics
    • 11.6.3. Polymeric
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 11.7.1. Epilepsy
    • 11.7.2. Depression
    • 11.7.3. Migraine
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Biomaterial
    • 12.3.4. By Application
  • 12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 12.4.1. GCC Countries
    • 12.4.2. Egypt
    • 12.4.3. South Africa
    • 12.4.4. Northern Africa
    • 12.4.5. Rest of Middle East & Africa
  • 12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 12.5.1. Implantable VNS Device
    • 12.5.2. External VNS Device
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
    • 12.6.1. Metallic
    • 12.6.2. Ceramics
    • 12.6.3. Polymeric
  • 12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 12.7.1. Epilepsy
    • 12.7.2. Depression
    • 12.7.3. Migraine
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Soterix Medical Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. MicroTransponder Inc
    • 13.3.3. Beijing PINS Medical Co., Ltd
    • 13.3.4. LivaNova PLC
    • 13.3.5. Neuropix Company Ltd.
    • 13.3.6. Parasym Ltd
    • 13.3.7. electroCore, Inc.
    • 13.3.8. tVNS Health GmbH
    • 13.3.9. SetPoint Medical Corporation

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations